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the life sciences are struggling with the challenges of diet and health. agriculture wrestles to become both more productive and more sustainable in the face of the world’s population growing past  billion. at the same time, in 
the most affluent parts of the world, diet-related diseases are considered to be the major 
threat to public health. The problems are complex; how can agriculture become simulta-
neously more productive and sustainable while foods become simultaneously safer, more 
nourishing and more delightful to our quality of life? The foods for Health Institute was 
established at UC Davis to promote research and development across the campus. The 
goal of the institute is to develop multi-disciplinary and multi-collaborative approaches 
to address these challenges and deliver on the bold promise to improve health and pre-
vent disease with food-based solutions. Promising to prevent disease (defined as not to 
cure disease or reverse the damage accumulated by disease, but to pre-emptively prevent 
disease from occurring) is indeed provocative. How can science address such an attrac-
tive yet seemingly insurmountable goal? one critical question for science and for food is 
at the core of the problem: what do we target to improve health in ways that ultimately 
reduce the risks of all diseases?
Preventing disease is a far-reaching goal. If healthcare approaches are truly preventa-
tive, then they act on individuals before diseases develop—any disease. If a food or food 
ingredient is developed to reduce the risk of one disease, but in so doing also increases 
the risk of any other disease, consumers aren’t healthier. The current strategy for treat-
ing diseases is built on a mature scientific foundation. Laboratory bench breakthroughs 
identify the causes of disease which become targets for diagnostic development to identify 
those afflicted with the disease. The same targets become the objects of high-throughput 
screening programs to identify candidate chemicals that could act to reverse disease, which 
in turn leads to their evaluation, testing and validation as small-molecule drugs. These 
pharmaceuticals are subsequently rolled out into a regulated, world-wide pharmaceutical 
industry and prescribed by trained clinical professionals as curative solutions to disease. 
Yet, if the goal is to prevent disease, then we cannot rely on diseases to define the scientific 
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targets on which to act. what are the targets for prevention? what mechanism do we act 
upon? what ingredients, when regularly ingested, are capable of acting on these targets 
and achieving this beneficial goal of overall prevention?
evolutionary Basis for Discovering Metabolic targets for 
Improving Health
Determining the targets for improving health is the fundamental problem of prevention. 
what are the targets, mechanisms of action and ingredients that we can discover that 
would make healthy people healthier? The good news is, an arsenal of “omic” technologies 
is at our disposal to approach this problem. The global scientific enterprise of genomics 
has sequenced various life forms. Science has now built this knowledge as a magnificent 
public resource; the entire genomic sequences of hundreds of viruses and bacteria, dozens 
of plants and animals and, of course, of Homo sapiens have been elucidated (Karolchik 
et al., 003; Pruitt et al., 00; Liolios et al., 00). what can genomics tell us about 
diet and health? an animal’s genome is its blueprint of evolution and the basis of each 
organism’s multiple solutions to its Darwinian pressures (Gould, 00). Understanding 
Darwinian pressures can reveal the basis for genetic outcomes. Plants exposed to a dry 
environment develop molecular strategies for water conservation. animals exposed to 
predators develop strategies for camouflage, protection or escape. to understand how 
animals have developed mechanisms of diet and prevention, we need a genomic model in 
which the Darwinian pressure was for nourishment and prevention. This basic scientific 
logic has been used previously in fields from pharmaceuticals to building construction. for 
example, the genomics of plants are mined to identify candidate drugs (oksman-Caldentey 
and Inzé, 00). Pharmaceutical companies have purchased the genetic rights to specific 
rainforests, reasoning that the jungle is full of candidate drugs (Mendelsohn and Balick, 
995). analyzing from the context of Darwinian pressure, it is clear that plants evolved 
in part to the threat of predation. Since they cannot run away, their defence has been 
to become chemical factories of selective toxicity (Xie and Lou, 009). The secondary 
metabolism of plants is an ingenious result of this pressure. Yet, our goal is not treatments 
for disease, but food-based solutions to achieve health.
what could possibly have emerged from millennia of evolution under the constant 
Darwinian pressures to be nourishing, protective, and to act on targets that improve the 
overall health of healthy animals? Milk. Lactation is the remarkable biological invention 
of mammals as the sole source of nourishment for post-natal infants.
Discovering the Darwinian Pressure of Milk as a Model for 
foods for Health
Through evolutionary experimentation, mammals have spent the last 0 million years 
developing “the most efficient, effective and adaptable means of postnatal nutrient 
provision that has ever arisen among vertebrates—lactation” (Blackburn, 993). Milk 
and lactation are an appropriate model to guide scientific discovery for foods for health. 
Lactation is appropriate for a wider range of activities than simply the chemicals in milk. 
The mammary epithelial cell is, in turn, itself a marvel of engineering: a bioreactor that 
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synthesizes bioactive components and guides the self-assembly of supra-molecular struc-
tures (German et al., 00). The constant Darwinian pressure on lactation has been to 
deliver a complete, absorbable ensemble of chemicals and structures that, when ingested, 
acts upon metabolic and physiologic targets that promote the competitive success of 
healthy mammals (ward and German, 00). This Darwinian pressure has led to the 
elaboration of complex food in milk that not only delivers nutrients as complex supra-
molecular structures (i.e. milk-fat globules, casein), but includes immune-modulatory, 
toxin-binding and growth factors and antimicrobial peptides and proteins that act within 
the intestine and beyond to promote health, growth and protection of the neonate. 
furthermore, safety and efficacy of milk has been rigorously tested during these same 
millions of years of evolution. Thus, unlike pharmaceutical research that must in every 
case ask: is it healthy? with milk, the question researchers need to ask is, “How does milk 
mechanistically elicit its health effects?”
Shifting the Paradigm for r&D: Disease treatment to 
Prevention
traditional drug development requires up to 0 years from candidate drug discovery to 
market, with greater than 90% of drugs failing during human trials (eliopoulos et al., 
00). The entire process from target discovery to successful intervention typically takes 
30 to 50 years. as a direct response to the length of time and poor success rate in which 
basic bench science is transformed into a breakthrough with clinical utility, the field of 
translational science under the nIH was initiated as a new multi-disciplinary field in which 
the stated objective is to bring science to practice (Zerhouni, 00). Yet, the current model 
of bringing science to practice is for the scientific discovery of pharmaceutical solutions 
to disease. This serial process requires the identification of pathways that are affected and 
their causal mechanisms—whether pathogens, toxins or enzymes. These causal mecha-
nisms become the target for pharmaceutical solutions. with in-vitro screening, thousands 
of molecules are tested for their ability to act upon the target. Subsequently, successful 
hits move to drug-development pipelines where their safety in animals and humans is 
tested and their efficacy is tested against the target and then the disease. finally, the small 
molecule found to act on the target is tested for efficacy, safety, and commercialization 
(tonkens, 005). The process of bringing scientific discovery to practice requires a quarter 
of a century. to speed up this process, key steps in this system will have to be accelerated. 
Yet, what part of translation of drugs should we skip: the efficacy or the safety?
If the translation of drugs for targeting disease requires decades of testing, how long 
would it take to discover, test, validate and bring to practice the prevention of disease by 
foods? a major challenge to prevention is actually in the time to translation. Prevention 
means that disease is prevented in healthy people. Do we wait an additional 50 years to 
assess the effectiveness in preventing disease by a food? fortunately, evolution has used 
0 million years for testing the efficacy anD safety of milk. for preventing disease with 
foods, research on milk at the foods for Health Institute has led to the adoption of a 
different translational model (figure ). Unlike use of serial development for discovering 
disease targets, health can be translated using parallel research and development. Based 
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on the basic evolutionary principle in which lactation evolved under the relentless pres-
sure to be nourishing, supportive and protective, once a molecule in milk is identified, 
it is understood that it is going to be valuable. It is only to be known how and in what 
population will it be effective. This confidence of efficacy suggests we can immediately 
start the process of developing industrial scale sources of the molecule, processing strate-
gies, analytics and diagnostics of its presence and actions. once populations that could 
benefit from consuming the molecule are identified and metabolic benefit is clinically 
assessed, ingredients and products are already scaled up for commercialization.
figure . Parallel research and development for translating health.
Discovering the Mechanistic targets of Milk through 
evolutionary Genomics
Identifying and annotating the milk genome is proving to be invaluable for the discovery 
of genes encoding molecules in human milk and their respective physiological targets. In 
efforts to provide a collaborative and interactive platform for researchers to accelerate the 
understanding of the biological processes underlying the mammalian milk genome, the 
International Milk Genomics Consortium (IMGC) was initiated in 00. The IMGC 
has constructed a web-based portal as a public resource consisting of the genes of lacta-
tion and their annotation for the unique roles they play as molecules and structures for 
nourishment (www.milkgenomics.org). research in this field extends across mammals 
and their varying lactation strategies, to provide insights into the diverse roles of milk 
(Bovine, 009; Lemay et al., 009). IMGC has acquired lactation genomes across the entire 
evolution of mammals which permit the pursuit of a wide variety of scientific questions 
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about the origins, functions and distributions of lactation genes and their specific quality 
traits. for example, two animal species with contrasting lactation strategies have evolved 
in response to unique natural selective pressures: the black bear and the hooded seal. 
The black bear of the northeastern United States and Canada gives birth during winter 
hibernation. The mother bear continues to hibernate for –3 months postpartum, during 
which time she does not exit the den to eat or drink despite nursing her cubs (oftedal 
et al., 00). This example in which maternal stores solely support the first few months 
of lactation is a model for nutritional efficiency. at the other end of the spectrum is the 
hooded seal. This mammalian pup is born on an ice floe in the north atlantic, in polar-
bear country. The strategy for the neonate is to get off the ice floe and into the open sea 
quickly. During the  days of lactation, the mother seal transfers  kg of fat from her 
adipose stores and the pup gains  kg, of which three quarters is visceral fat. This most 
remarkable example of energy transfer in mammals supports the young seal through a 
post-weaning fasting period of 5–0 weeks (oftedal et al., 00).
one over-arching question relates to the rate of evolution of lactation itself. Given 
the basic principle that mutations accumulate during evolution, the more identical the 
sequences are for a given protein, logic and prior experimentation have documented 
that the more important its sequence is to the survival of the organism. By taking such 
a quantitative perspective to evolution, lactation has been vital to the success of mam-
mals. In figure , the sequence identity of proteins expressed from genes in the entire 
genomes of seven mammals is distributed and compared with the proteins expressed by 
lactation genes of the same mammals. Most of the milk proteins are highly conserved 
across mammals, whereas a much smaller subset is highly divergent across mammals. 
There is less conservation among mammals for proteins of the liver, adipose, and brain 
than for lactation-related genes. This conservation throughout evolution emphasizes how 
important these genes have been to the survival of the species. even evolution agrees that 
we have chosen the right model. 
a Success Story for foods for Health
recall our model, the mother-infant pair. The mammalian mother actively dissolves her 
tissues to make milk. everything in the milk is costly to the mother. If components found 
in milk do not enhance the survival of the infant, the cost to the mother would lead to 
its loss through evolution. However, if any component in milk, when consumed by the 
infant, provides it any competitive advantage over its genetic peers, it will be retained in 
evolution. This mother-infant pair is a Darwinian engine of nutrition. Considering this 
model, imagine to our surprise when we examined the various components in human 
milk and found that the third most abundant component class, at key stages of lactation 
more abundant than protein, were indigestible by the infant (Zivkovic et al., 00). How 
could this be? 
Discovery
The presence of indigestible saccharides in milk led to a multi-disciplinary pursuit. robert 
ward, in Bruce German’s laboratory, recognizing their paradoxical abundance, isolated 
these molecules from human milk and began to characterize their structures and func-
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tions (ward et al. 00), although methods to characterize the chemical structures of 
these components were largely lacking. Their structural determination is one of the most 
complex problems for analytical chemistry. Carlito Lebrilla, a world leader in glycan 
analytics, and his team developed the tools to characterize the structures of the oligosac-
charides in milk (ninonuevo et al., 00, 00, 00; tao et al., 009, 00). If the 
infant cannot digest oligosaccharides, what are their functions? David Mills, a leading 
microbiologist specializing in the bacteria of the intestine, and his team characterized 
one component of the intestinal microbiota—Bifidobacterium infantis—which digested 
and thrived on oligosaccharides purified from human milk as their only carbon source 
(Sela et al., 00). This bacterial species was first isolated from the intestine of breast-fed 
infants. This is when the genius of milk became clear. Mothers are recruiting another life 
form: bacteria that protect their infants’ health. These results have identified a unique 
target for foods; the intestinal microflora anD how to alter its population to derive a 
health benefit (Zivkovic et al., 00). 
Translation
one advantage of doing research at the University of California at Davis is the breadth 
and depth of scientific and clinical programs across campus. Mark Underwood, the head 
of the neonatology Unit at the UC Davis Medical Center has been pursuing intestinal 
health as a target of success and failure for premature infants. Mark and his colleagues are 
now investigating the use of human milk oligosaccharides and Bifidobacterium infantis 
to protect premature infants at increased risk of intestinal disease. 
figure . Distribution of proteins expressed by lactation-related and total 
genomes of seven mammals.
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Commercialization
The final test of translational science is bringing it to practice for appropriate consumers. 
from the beginning of the project we have been simultaneously developing sources and 
technologies to produce this unique class of oligosaccharides as a food ingredient. Sources 
such as dairy process streams to decorated oligosaccharides, are all candidates that could 
achieve structure-function benefits of human-milk oligosaccharides. The UC Davis Center 
for entrepreneurship is working in parallel to define business models for this ingredient 
class to enter the food marketplace. The goal is to translate health to those who would 
most immediately benefit from consuming such ingredients. 
Conclusions
The challenges facing the life sciences and the entire agriculture enterprise are to deliver on 
the promise of prevention. The models established for small molecules as drugs developed 
by the pharmaceutical industry and delivered through the clinical profession as curative 
therapeutics are not appropriate for foods for prevention. This failure does not mean that 
we compromise the quality of science, the rigors of regulation nor the expectations for 
efficacy. new models that are capable of enhancing safety, efficacy and personal benefits 
from foods constitute the st century’s most vivid opportunity to improve the human 
condition. The University of California, Davis, has assembled the multiple disciplines to 
respond to such an opportunity. 
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